Literature DB >> 32032734

Dysregulated iron metabolism in C. elegans catp-6/ATP13A2 mutant impairs mitochondrial function.

Nikhita Anand1, Angelina Holcom1, Michael Broussalian1, Minna Schmidt1, Shankar J Chinta2, Gordon J Lithgow1, Julie K Andersen3, Manish Chamoli4.   

Abstract

Mutations in the human ATP13A2 gene are associated with an early-onset form of Parkinson's disease (PD) known as Kufor Rakeb Syndrome (KRS). Patients with KRS show increased iron deposition in the basal ganglia, suggesting iron toxicity-induced neurodegeneration as a potential pathogenesis associated with the ATP13A2 mutation. Previously we demonstrated that functional losses of ATP13A2 disrupt the lysosomes ability to store excess iron, leading to reduce survival of dopaminergic neuronal cells. To understand the possible mechanisms involved, we studied a Caenorhabditis elegans mutant defective in catp-6 function, an ortholog of human ATP13A2 gene. Here we show that catp-6 mutant worms have defective autophagy and lysosomal function, demonstrate characteristic PD phenotypes including reduced motor function and dysregulated iron metabolism. Additionally, these mutants have defective mitochondrial health, which is rescuable via iron chelation or mitophagy induction.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ATP13A2; C. elegans; Catp-6; Iron chelation; Iron metabolism; Lysosomes; Mitochondrial function; Parkinson's disease; TFEB; Urolithin A

Mesh:

Substances:

Year:  2020        PMID: 32032734      PMCID: PMC7150649          DOI: 10.1016/j.nbd.2020.104786

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  34 in total

Review 1.  Maintenance of C. elegans.

Authors:  Theresa Stiernagle
Journal:  WormBook       Date:  2006-02-11

2.  Urolithin A induces mitophagy and prolongs lifespan in C. elegans and increases muscle function in rodents.

Authors:  Dongryeol Ryu; Laurent Mouchiroud; Pénélope A Andreux; Elena Katsyuba; Norman Moullan; Amandine A Nicolet-Dit-Félix; Evan G Williams; Pooja Jha; Giuseppe Lo Sasso; Damien Huzard; Patrick Aebischer; Carmen Sandi; Chris Rinsch; Johan Auwerx
Journal:  Nat Med       Date:  2016-07-11       Impact factor: 53.440

3.  Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase.

Authors:  Alfredo Ramirez; André Heimbach; Jan Gründemann; Barbara Stiller; Dan Hampshire; L Pablo Cid; Ingrid Goebel; Ammar F Mubaidin; Abdul-Latif Wriekat; Jochen Roeper; Amir Al-Din; Axel M Hillmer; Meliha Karsak; Birgit Liss; C Geoffrey Woods; Maria I Behrens; Christian Kubisch
Journal:  Nat Genet       Date:  2006-09-10       Impact factor: 38.330

4.  Pallido-pyramidal degeneration, supranuclear upgaze paresis and dementia: Kufor-Rakeb syndrome.

Authors:  A S Najim al-Din; A Wriekat; A Mubaidin; M Dasouki; M Hiari
Journal:  Acta Neurol Scand       Date:  1994-05       Impact factor: 3.209

Review 5.  Cellular signal transduction of the hypoxia response.

Authors:  Koh Nakayama
Journal:  J Biochem       Date:  2009-10-28       Impact factor: 3.387

6.  Translocation of iron from lysosomes into mitochondria is a key event during oxidative stress-induced hepatocellular injury.

Authors:  Akira Uchiyama; Jae-Sung Kim; Kazuyoshi Kon; Hartmut Jaeschke; Kenichi Ikejima; Sumio Watanabe; John J Lemasters
Journal:  Hepatology       Date:  2008-11       Impact factor: 17.425

7.  Cd2+, Mn2+, Ni2+ and Se2+ toxicity to Saccharomyces cerevisiae lacking YPK9p the orthologue of human ATP13A2.

Authors:  Karyn Schmidt; Devin M Wolfe; Barbara Stiller; David A Pearce
Journal:  Biochem Biophys Res Commun       Date:  2009-04-05       Impact factor: 3.575

8.  Hypothesis-based RNAi screening identifies neuroprotective genes in a Parkinson's disease model.

Authors:  Shusei Hamamichi; Renee N Rivas; Adam L Knight; Songsong Cao; Kim A Caldwell; Guy A Caldwell
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-08       Impact factor: 11.205

9.  STRING v10: protein-protein interaction networks, integrated over the tree of life.

Authors:  Damian Szklarczyk; Andrea Franceschini; Stefan Wyder; Kristoffer Forslund; Davide Heller; Jaime Huerta-Cepas; Milan Simonovic; Alexander Roth; Alberto Santos; Kalliopi P Tsafou; Michael Kuhn; Peer Bork; Lars J Jensen; Christian von Mering
Journal:  Nucleic Acids Res       Date:  2014-10-28       Impact factor: 16.971

10.  ATP13A2 (PARK9) protein levels are reduced in brain tissue of cases with Lewy bodies.

Authors:  Karen E Murphy; Louise Cottle; Amanda M Gysbers; Antony A Cooper; Glenda M Halliday
Journal:  Acta Neuropathol Commun       Date:  2013-05-09       Impact factor: 7.801

View more
  10 in total

Review 1.  Mitophagy and reactive oxygen species interplay in Parkinson's disease.

Authors:  Bin Xiao; Joshua Kuruvilla; Eng-King Tan
Journal:  NPJ Parkinsons Dis       Date:  2022-10-18

2.  Gossypitrin, A Naturally Occurring Flavonoid, Attenuates Iron-Induced Neuronal and Mitochondrial Damage.

Authors:  María Ángeles Bécquer-Viart; Adonis Armentero-López; Daniel Alvarez-Almiñaque; Roberto Fernández-Acosta; Yasser Matos-Peralta; Richard F D'Vries; Javier Marín-Prida; Gilberto L Pardo-Andreu
Journal:  Molecules       Date:  2021-06-02       Impact factor: 4.411

3.  Maackiain Ameliorates 6-Hydroxydopamine and SNCA Pathologies by Modulating the PINK1/Parkin Pathway in Models of Parkinson's Disease in Caenorhabditis elegans and the SH-SY5Y Cell Line.

Authors:  Rong-Tzong Tsai; Chia-Wen Tsai; Shih-Ping Liu; Jia-Xin Gao; Yun-Hua Kuo; Pei-Min Chao; Huey-Shan Hung; Woei-Cherng Shyu; Shinn-Zong Lin; Ru-Huei Fu
Journal:  Int J Mol Sci       Date:  2020-06-23       Impact factor: 5.923

4.  Highly exposed segment of the Spf1p P5A-ATPase near transmembrane M5 detected by limited proteolysis.

Authors:  Guido D Petrovich; Gerardo R Corradi; Carlos H Pavan; Sofia Noli Truant; Hugo P Adamo
Journal:  PLoS One       Date:  2021-01-28       Impact factor: 3.240

Review 5.  Modelling the functional genomics of Parkinson's disease in Caenorhabditis elegans: LRRK2 and beyond.

Authors:  Rachael J Chandler; Susanna Cogo; Patrick A Lewis; Eva Kevei
Journal:  Biosci Rep       Date:  2021-09-30       Impact factor: 3.840

Review 6.  Autophagy in the Neuronal Ceroid Lipofuscinoses (Batten Disease).

Authors:  William D Kim; Morgan L D M Wilson-Smillie; Aruban Thanabalasingam; Stephane Lefrancois; Susan L Cotman; Robert J Huber
Journal:  Front Cell Dev Biol       Date:  2022-02-16

7.  ATP13A2 protects dopaminergic neurons in Parkinson's disease: from biology to pathology.

Authors:  Tao Dang; Wen-Jing Cao; Rong Zhao; Ming Lu; Gang Hu; Chen Qiao
Journal:  J Biomed Res       Date:  2022-03-28

Review 8.  Mitochondrial Dysfunction in Parkinson's Disease: From Mechanistic Insights to Therapy.

Authors:  Xiao-Yan Gao; Tuo Yang; Ying Gu; Xiao-Hong Sun
Journal:  Front Aging Neurosci       Date:  2022-06-20       Impact factor: 5.702

9.  Synthesis of Melatonin Derivatives and the Neuroprotective Effects on Parkinson's Disease Models of Caenorhabditis elegans.

Authors:  Li He; Jing-Jing Du; Jun-Jie Zhou; Meng-Ting Chen; Lu Luo; Bao-Qiong Li; Xiang-Zhi Zhang; Wen-Zhe Ma; Ai-Jun Ma; Na Feng
Journal:  Front Chem       Date:  2022-06-08       Impact factor: 5.545

10.  Swimming exercise reduces native ⍺-synuclein protein species in a transgenic C. elegans model of Parkinson's disease.

Authors:  Minna Y Schmidt; Manish Chamoli; Gordon J Lithgow; Julie K Andersen
Journal:  MicroPubl Biol       Date:  2021-06-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.